Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 7, 2025
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how often kidney problems occur in children with Tuberous Sclerosis Complex (TSC), a condition that can cause growths in various organs. Researchers are looking at medical records from pediatric patients under 17 years old who were diagnosed with TSC between January 2018 and June 2021. The goal is to better understand how TSC affects the kidneys and to gather important information that could help improve care for these patients.
To participate in this study, children must be under 17 years old at the time of their last medical visit and have been evaluated for TSC during the specified timeframe. Their parents or guardians will need to sign a consent form to allow them to be part of the study. Participants will not need to undergo any new treatments or procedures specifically for this study; instead, researchers will review existing medical records to gather the necessary information. This study is important because it aims to shed light on kidney involvement in TSC, which can help healthcare providers better manage this condition in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients of either sex under the age of 17 years at the time of last observation (06/30/2021);
- • Patients clinically evaluated in an outpatient or inpatient setting during 01/01/2018- 30/06/2021 with a diagnosis of TSC;
- • Informed consent signed by parent or legal guardian.
- Exclusion Criteria:
- • Patients older than 18 years of age;
- • Patients with other phacomatoses.
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Andrea Pasini, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported